Your browser doesn't support javascript.
loading
Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial.
Vergote, Ignace; Scambia, Giovanni; O'Malley, David M; Van Calster, Ben; Park, Sang-Yoon; Del Campo, Josep M; Meier, Werner; Bamias, Aristotelis; Colombo, Nicoletta; Wenham, Robert M; Covens, Al; Marth, Christian; Raza Mirza, Mansoor; Kroep, Judith R; Ma, Haijun; Pickett, Cheryl A; Monk, Bradley J.
Afiliación
  • Vergote I; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; European Network of Gynaecological Oncological Trial groups (ENGOT), Divison of Gynecologic Oncology, Leuven Cancer Institute, KU Leuven, Leuven, Belgium. Electronic address: ignace.vergote@uzleuven.be.
  • Scambia G; Multicenter Italian Trials in Ovarian Cancer Society (MITO), Rome, Italy; Fondazione Policlinico Universitario A Gemelli, Istituto di Ricovero e Cura a Carattere Scientifico, Università Cattolica, Rome, Italy.
  • O'Malley DM; Gynecologic Oncology Group, James Comprehensive Cancer Center, Ohio State University, Columbus, OH, USA.
  • Van Calster B; Belgium and Luxembourg Gynaecological Oncology Group (BGOG), Leuven, Belgium; Department of Development and Regeneration, KU Leuven, Leuven, Belgium; Department of Biomedical Data Sciences, Leiden University Medical Centre, Leiden, Netherlands.
  • Park SY; National Cancer Center, Goyang, South Korea.
  • Del Campo JM; Grupo Español de Investigación en Cáncer de Ovario (GEICO), Department of Medical Oncology, Vall d'Hebron University Hospital, Barcelona, Spain.
  • Meier W; Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO), Department of Gynecology and Obstetrics, AGO-Germany and Evangelic Hospital Düsseldorf, Düsseldorf, Germany.
  • Bamias A; Department of Clinical Therapeutics, Alexandra Hospital, National & Kapodistrian University of Athens, Athens, Greece; Hellenic Cooperative Oncology Group (HECOG), Athens, Greece.
  • Colombo N; Mario Negri Gynecologic Oncology Group (MANGO), European Institute of Oncology, Istituto di Ricovero e Cura a Carattere Scientifico, Milan, Italy; Università Milano Bicocca, Milan, Italy.
  • Wenham RM; Gynecologic Oncology Group, Department of Gynecologic Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
  • Covens A; Division of Gynecologic Oncology, Toronto Sunnybrook Regional Cancer Center, University of Toronto, Toronto, ON, Canada.
  • Marth C; Arbeitsgemeinschaft Gynaekologische Onkologie Study Group (AGO)-Austria, Department of Obstetrics and Gynecology, Medical University of Innsbruck, Innsbruck, Austria.
  • Raza Mirza M; Nordic Society of Gynaecological Oncology (NSGO), Department of Oncology, Rigshospitalet, Copenhagen, Denmark.
  • Kroep JR; Dutch Gynecological Oncology Group (DCOG), Department of Medical Oncology, Leiden University Medical Center, Leiden, Netherlands.
  • Ma H; Global Development Oncology, Amgen, Thousand Oaks, CA, USA.
  • Pickett CA; Global Development Oncology, Amgen, Thousand Oaks, CA, USA.
  • Monk BJ; Gynecologic Oncology Group, Arizona Oncology (US Oncology Network), University of Arizona, Phoenix, AZ, USA; Creighton University, Phoenix, AZ, USA.
Lancet Oncol ; 20(6): 862-876, 2019 06.
Article en En | MEDLINE | ID: mdl-31076365
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Neoplasias de las Trompas Uterinas / Carcinoma Epitelial de Ovario Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Neoplasias Peritoneales / Protocolos de Quimioterapia Combinada Antineoplásica / Terapia Recuperativa / Neoplasias de las Trompas Uterinas / Carcinoma Epitelial de Ovario Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Middle aged Idioma: En Revista: Lancet Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article